SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: johnsto1 who wrote (1710)9/20/2000 6:53:46 PM
From: Biomaven  Read Replies (1) | Respond to of 52153
 
j1,

The bios vs. the pharmas have pretty much been tracking the Nasdaq vs. Dow battle for the last few weeks. So I haven't seen anything special in the biotechs' behavior.

Don't know of any impending overall developments. I am seeing some expressions of valuation concerns among the upper tiers, though.

To partially hedge myself I've sold some calls on the BTK index. Still very much net long, though.

Peter